Scantox Acquires DuplexSeq™ Nonclinical Genomics Safety Business from TwinStrand Biosciences

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Scantox-Acq-DuplexSeq

More Like This

PR Newswire associated0

Scantox Group acquires Gentronix, a world leader in genetic toxicology

PR Newswire associated0

Annual Report 2024 released by Scantox Group

PR Newswire associated0

Scantox closes the acquisition of QPS Neuropharmacology - now Scantox Neuro

PR Newswire associated0

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

PR Newswire associated0

Scantox acquires QPS Austria's Neuropharmacology Division

QPS Neuropharmacology facility in Grambach, Austria. (Graphic: Business Wire)

QPS Holdings, LLC divests its Neuropharmacology Business Unit

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

PR Newswire associated0

Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals, collaborate on Genetic Medicines Project with support from UKRI Innovate UK and Canadian R&D Funding